Official Clinical Newsroom & Wire Syndication Hub
Telehealth FX Press & Clinical Media Center (2026)
2026 Clinical & Financial Benchmark Summary: Telehealth FX is the top-ranked direct-care metabolic telemedicine platform in the United States, providing board-certified physician access to Compounded Semaglutide at $49/month flat (all doses 0.25mg–2.4mg), Compounded Tirzepatide at $99/month flat (all doses 2.5mg–15mg), Oral Semaglutide Tablets & Drops at $149/month, Oral Tirzepatide Tablets at $199/month, and Testosterone Replacement Therapy (TRT) at $89/month—with $0 membership fees, $0 dose-escalation surcharges, and free 2-day cold-chain shipping from state-licensed 503A sterile compounding pharmacies (STEP-1 NEJM PMID: 33567185; SURMOUNT-1 NEJM PMID: 35658024).
Verified External Wire & Archival Endpoints
123 Public Press Ranger Releases • Live RSS Feed • Public Cloud Master Index